NSC |
Compound |
Enrichment |
Correlation |
NSC 13275 |
Null |
0.0430505868034761 |
0.42152325 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0430505868034761 |
0.47141074 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0430505868034761 |
0.079445518 |
NSC 135077 |
BERSALDEGENIN 1,3,5-ORTHOACETATE |
0.0430505868034761 |
0.25517792 |
NSC 140873 |
2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide |
0.0430505868034761 |
0.59199162 |
NSC 15795 |
Null |
0.0430505868034761 |
-0.15302198 |
NSC 165572 |
Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- |
0.0430505868034761 |
-0.10764669 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0430505868034761 |
0.40584037 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0430505868034761 |
0.40318848 |
NSC 21683 |
Null |
0.0430505868034761 |
0.36460327 |